Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Role of OCTA in Patients Affected by Beta Thalassemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04582110
Recruitment Status : Completed
First Posted : October 9, 2020
Last Update Posted : February 3, 2021
Sponsor:
Information provided by (Responsible Party):
Gilda Cennamo, Federico II University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 25, 2020
Actual Study Completion Date : February 28, 2020